Recent Advances in Biotransformation of CNS and Cardiovascular Agents

Current Drug Metabolism

Volumn 1, Issue 3, 2000, Pages 255-270

  Wu, W N ^a   McKown, L A ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ANIMAL; BIOTRANSFORMATION; HUMAN; REVIEW;

ANIMALS; BIOTRANSFORMATION; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS;

EID: 0034329399     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200003338965     Document Type: Article

References (88)

1. Reitz, A.B.; Bennet, D.J.; Blum, P.S.; Codd, E.E., Maryanoff, C.A.; Ortegon, M.E.; Renzi, M.J.; Scott, M.K.; Shank, R.P. and Vaught, J.L. (1994) J. Med. Chem., 31, 1060-1062.
2. Reitz, A.B. and Scott, M.K. (1995) in Advances in Medicinal Chemistry (Maryanoff, B.E. and Maryanoff, C.A., Eds.), JAI: Greenwich 3, pp.1-56.
3. nd ASMS Conference on Mass Spectometry and Allied Topics, 344.
4. Wu, W.N.; McKown, L.A.; Takacs, A.R.; Jones, W.J. and Reitz, A.B. (1999) Xenobiotica, 29(5), 453-466.
5. Reitz, A.B.; McDonnell, M.E.; Baxter, E.W.; Codd, E.E. and Wu, W.N. (1997) Bioorgan.& Med. Chem. Letters, 7(14), 1927-1930.
6. Wu, W.N.; McKown, L.A.; Gauthier, A.D.; Jones, W.J. and Takacs, A.R. (1994) Pharm. Res., 11(10), S-344.
7. rd ASMS Conference and Allied Topics, 527.
8. tm, 1(1), S-36.
9. Wu, W.N.; McKown, L.A.; Takacs, A.R. and Reitz, A.B. (1997) ISSX Proceedings, 11: 161.
10. Wu, W.N.; McKown, L.A.; Moyer, M.D. and Reitz, A.B. (2000) J. Pharm & Biomed. Analy., In press.
11. Janssen, P.A.J.; Niemegeers, C.J.E.; Awouters, F.; Schellekens, K.H.L.; Megens, A.A.H.P. and Meert, T.F. (1988) J. Pharmacol. Exper. Ther., 244(2), 685-693.
12. Leysen, J.E.; Gommeren, W.; Eens, A.; De Courcelles, D.D.C.; Stoof, J.C. and Janssen, P.A.J. (1988) J. Pharmacol. Exper.Ther., 247(2), 661-670.
13. Gelders, Y.G.; Heylen, S.L.E.; Bussche, G.V.; Reyntjens, A.J.M. and Janssen, P.A.J. (1990) Phramacopsychiat, 23, 206-211.
14. Mannens, G.; Huang, M.L.; Meuldermans, W.; Hendrickx, J.; Woestenborghs, R. and Heykants, J. (1993) Drug Metab. Dispos., 21(6), 1134-1141.
15. Meuldermans, W.; Hendrickx, J.; Mannens, G.; Lavrijsen, K.; Janssen, C.; Bracke, J.; Le Jeune, L.; Lauwers, W. and Heykants, J. (1994) Drug Metab. Dispos., 22(1), 129-138.
16. Ramacci, M.T; Ghirardi, O.; Maccari, F.; Pacifici, L. and Sal, P. (1979) Arzneim.-Forsch., 29, 294-307.
17. Przegalinski, E. and Lewandowska, A. (1979) J. Neural Transm., 46, 303-312.
18. Cioli, V.; Carradino, C.; Piccinelli, D.; Rocchi, W.G. and Valeri, P. (1984) Pharmacol. Res. Commun. 16, 85-100.
19. Martin, G.E.; Mathiasen, J.R. and Kesslick, J.M. (1989) Psychopharmacology, 99, 94-97.
20. Raffa, R.B.; Shank, R.P. and Vaught, J.L. (1992) Psychopharmacology, 108, 320-326.
21. Bolden-Watson, C. and Richelson, E. (1993) Life Sci., 52, 1023-1029.
22. Caccia, S. (1990) Boll. Chim. Farm., 129, 183-189.
23. Garattini, S. (1985) Clin. Pharmacokinet., 10, 216-217.
24. Fong, M.H.; Garattini, S. and Caccia, S. (1982) J. Pharm. Pharmacol., 34, 474-675.
25. th Inter. Symp. on Pharm. & Biomed. Analy., 19.
26. Wu, W.N.; Masucci, J.A.; McKown, L.A. and Rodgers, J.D. (1995) J. Pharm. & Biomed. Analy., 13(2), 177-184.
27. Wu, W.N.; Caldwell, G.W. and Uetz, J.A. (1991) Pharmacologist, 33(30), 208.
28. Wu, W.N.; Caldwell, G.W. and Masucci, J.A. (2000) Xenobiotica, Submitted.
29. McKown, L.A. and Wu, W.N. (1996) The FASEB J., 10, 3.
30. Jauch, R. (1976) Arzneim.-Forsch., 26(11), 2082-2089.
31. Mayol, R.F.; Cole, C.A.; Luke, G.M.; Colson, K.L. and Kerns, E.H. (1994) Drug Metab. Dispos., 22(2), 304-311.
32. Prakash, C.; Kamel, A.; Gummerus, J. and Wilner, K. (1997) Drug Metab. Dispos., 25(7), 863-872.
33. Prakash, C.; Kamel, A. and Cui, D. (1997) Drug Metab. Dispos., 25(7), 897-901.
34. Rasmussen, C.R. (1976) US Patent, No.3,983,135.
35. Fabre, F.L. (1977) Clin. Res., 25, 269A.
36. Itil, T.M.; Seaman, P.A.; Hugue, M.; Mukhopadhyay, S.; Biasucci, D.; Ng, K.T. and Ciccone, P.E. (1978) Curr. Ther. Res. Clin. Exp., 24, 708-724.
37. Pecknold, J.C; McClure, D.J. and Appletauer, L. (1982) J.Clin.Psychopharmacology, 2, 129-133.
38. Goldberg, M.E.; Salama, A.I.; Patel, J.B. and Malick, J.B. (1983) Neuropharmacology, 22, 1499-1504.
39. th ASMS Annual Conference on Mass Spectrometry and Allied Topics, 88.
40. Wu, W.N.; McKown, L.A. and O'Neill, P.J. (1995) J. Pharm. Sci., 84(2), 185-189.
41. Gardocki, J.F.; Hageman, W.E. and Press, T.P. (1978) Arch. Inter.de Pharmacody.et de Ther.233, 326-342.
42. Rasmussen, C.R. (1975) US Patent No. 3876658.
43. Rasmussen, C.R.; Gardocki, J.F.; Plampin, J.N.; Twardzik, B.L.; Reynolds, B.E.; Molinari, A.J.; Schwartz, N.; Bennetts, W.W.; Price, B.E. and Marakowaski, J. (1978) J. Med. Chem., 21, 1044-1054.
44. Wu, W.N.; Hills, J.F.; Egan, R.S.; Ng, K.T.; Grindel, J.M. and O'Neill, P.J. (1983) Pharmacologist, 25(3), 381.
45. Wu, W.N.; Hills, J.F. and Egan, R.S. (1994) Xenobiotica, 24(7), 649-662.
46. Wu, W.N. and Mutter, M.S. (1995) J. Pharm. Biomed. Analy., 13, 857-867.
47. Wu, W.N. (1998) J. Pharm. Biomed. Analy., 17, 689-697.
48. Maryanoff, B.E.; Nortey, S.O.; Gardocki, J.F.; Shank, R.P. and Dodgson, S.P. (1987) J. Med. Chem., 30, 880-887.
49. Maryanoff, B.E. and Margul, B.L. (1989) Drugs Future, 14, 342-344.
50. Shank, R.P.; Gardocki, J.F.; Vaught, J.L.; Davis, C.B.; Schupsky, J.J.; Raffa, R.B.; Dodgson, S.J.; Nortey, S.O. and Maryanoff, B.E. (1994) Epilepsia, 35, 450-460.
51. Ben-Menachem, E.; Henriksen, O.; Dam, M.; Mikkelsen, M.; Schmidt, D.; Reid, S.; Reife, R.; Kramer, L.; Pledger, G. and Karim, R. (1996) Epilepsia, 37, 539-543.
52. nd ASMS Conference on Mass Spectrometry and Allied Topics, 59.
53. th ASMS Conference on Mass Spectrometry and Allied Topics, 244.
54. Wu, W.N.; Heebner, J.B.; Streeter, A.J.; Moyer, M.D.; Takacs, A.R.; Doose, D.R. and Ferraiolo, B.L. (1994) Pharm. Res. 11(10), S-336.
55. Nortey, S.O.; Wu, W.N. and Maryanoff, B.E. (1997) Carbohydrate Res.304, 29-38.
56. McKown, L.A.; Wu, W.N. and Takacs, A.R. (1994) The AAPS Eastern Regional Meeting Abstract.
57. Cosnier, D.; Duchene-Marullaz, P.; Rispat, G. and Streichenberger, G. (1977) Arch. Inter. de Pharmacody. et de Ther., 225, 133-151.
58. Harder, D.R. and Sperelakis, N. (1981) J. Cardiovas. Pharmacol., 5, 506-510.
59. Dibianco, R.; Alpert, J.; Katz, R.J.; Spann, J.; Chester, E.; Ferr, D.; Larca, L.J.; Costello, R.B.; Core, J.M.; Eisenman, M.J.; Cockrell, J.L. and Pauls, J.F. (1984) Amer. J. Cardiology, 53, 35-41.
60. Wu, W.N.; Ng, K.T. and Hills, J.F. (1984) Federation Proceedings, 43(3), 1599.
61. Ng, K.T.; Hills, J.F. and Wu, W.N. (1984) Federation Proceedings, 43(3), 2166.
62. Wu, W.N.; Hills, J.F.; Chang, S.Y. and Ng, K.T. (1988) Drug Metab. Dispos., 16(1), 69-77.
63. Wu, W.N.; Pritchard, J.F.; Ng, K.T.; Hills, J.F.; Uetz, J.A.; Yorgey, K.A.; McKown, L.A. and O'Neill, P.J. (1992) Xenobiotica, 22(2), 153-169.
64. th ASMS Conference on Mass Spectrometry and Allied Topics, 246.
65. Fleckenstein, A. (1997) Circ. Res., 52: 1-16.
66. Fleckenstein, A. (1984) Calcium antagonists and cardiovascular disease (Opie LH ed.). Raven Press, New York, pp. 9-28.
67. Marion Labs. (1988) Drugs of the Future. 13: 629-633.
68. Bean, B.P. (1984) Proc. Natl. Acad. Sci. USA, 81: 6388-6392.
69. McIlhenny, H.M. (1971) J Med. Chem., 14(12), 1178-1184.
70. Nelson, W.L.; Olsen, L.D.; Beitner, D.B. and Pallow, R.J. Jr. (1988), Drug Metab. Dispo., 16(2), 184-188.
71. Nelson, W.L. and Olsen, L.D. (1988), Drug Metab. Dispos., 16(6), 834-841.
72. Eichelbaum, M., Ende, M., Remberg, G., Schomerus, M. and Dengler, H.J. (1979) Drug Metab. Dispos., 7(3), 145-148.
73. Carson, J.R. (1987) US Patent No. 4,661,635.
74. Carson, J.R.; Almond, H.R.; Brannan, M.D.; Carmosin, R.J.; Flaim, S.F.; Gill, A.; Gleason, M.M.; Keely, S.L.; Ludovici, D.W.; Pitis, P.M., Rebarchak, M.C. and Villani, F.J. (1988) J. Med. Chem., 31, 630-636.
75. McNeil Pharm. (1989) Drugs of the Future, 14(4), 322-324.
76. McNeil Pharm. (1992) Drugs of the Future, 17(4), 344.
77. Flaim, S.F.; Gleason, M.M.; Hedberg, A.; Shank, R.P.; McCullough, J.R.; Gill, A.; Damiano, B.P.; Brannan, M.D. and Carson, J.R. (1991) J. Pharmacol. Exper. Ther. 256, 279-288.
78. Wu, W.N.; Masucci, J.A. and Caldwell, G.W. (1991) FASEB J., 5, 4862.
79. Wu, W.N.; Masucci, J.A.; Caldwell, G.W. and Carson, J.R. (1998) Drug Metab. Dispos., 26(2), 115-125.
80. Wu, W.N.; Masucci, J.A. and Caldwell, G.W. (1998) Xenobiotica, 28(10), 957-972.
81. Wu, W.N. and McKown, L.A. (1996) ISSX Proceedings, 10, 333.
82. McComsey, D..F. and Zelesko, M.J. (1977) US Patent, No. 4,059,583.
83. Pruss, T.P.; Hageman, W.E. and Jacoby, H.I. (1980) J: Pharmacol. Exper. Ther., 212, 514-518.
84. Zelesko, M.J.; McComsey, D.F.; Hageman, W.F.; Nortey, S.O.; Baker, C.A. and Maryanoff, B.E. (1983) J. Med. Chem., 28, 230-237.
85. McKown, L.A.; Wu, W.N. and Pritchard, J.F. (1992) AAPS Eastern Regional Meeting Abstract, 32.
86. Wu, W.N.; McKown, L.A.; Yorkey, K.A. and Pritchard, J.F. (1999) J. Pharm. & Biomed. Analy., 20, 687-695.
87. Taylor, D.C.; Cresswell, P.R. and Bartlett, D.C. (1978) Drug Metab. Dispos., 6, 21-30.
88. Taylor,D.C.; Cresswell,P.R.and Pepper,E.S. (1979) Drug Metab. Dispos.,7, 393-398.